Guoquan Gao Selected Research

Neoplasm Metastasis (Metastasis)

12/2021	FUBP1 promotes colorectal cancer stemness and metastasis via DVL1-mediated activation of Wnt/β-catenin signaling.
7/2018	Correction: Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis.
6/2017	Kallistatin exerts anti-lymphangiogenic effects by inhibiting lymphatic endothelial cell proliferation, migration and tube formation.
1/2017	Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis.
5/2016	Manganese superoxide dismutase mediates anoikis resistance and tumor metastasis in nasopharyngeal carcinoma.
11/2014	Pigment epithelium-derived factor (PEDF) inhibits breast cancer metastasis by down-regulating fibronectin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guoquan Gao Research Topics

Disease

25	Neoplasms (Cancer) 01/2022 - 12/2005
10	Hypoxia (Hypoxemia) 10/2017 - 03/2002
7	Inflammation (Inflammations) 10/2019 - 11/2005
6	Neoplasm Metastasis (Metastasis) 12/2021 - 11/2014
6	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2017 - 12/2005
5	Obesity 01/2021 - 09/2013
5	Carcinoma (Carcinomatosis) 12/2014 - 12/2007
5	Retinal Neovascularization 01/2012 - 03/2002
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 07/2013
4	Breast Neoplasms (Breast Cancer) 01/2020 - 09/2012
4	Stomach Neoplasms (Stomach Cancer) 01/2019 - 01/2014
4	Nasopharyngeal Carcinoma 07/2018 - 10/2011
4	Corneal Neovascularization 05/2013 - 11/2005
4	Ischemia 01/2012 - 03/2002
3	Burns 05/2013 - 11/2005
2	Kidney Neoplasms (Kidney Cancer) 01/2020 - 07/2016
2	Liver Neoplasms (Liver Cancer) 01/2020 - 10/2010
2	Insulin Resistance 01/2019 - 09/2013
2	Body Weight (Weight, Body) 01/2019 - 05/2018
2	Lymphatic Metastasis 01/2019 - 01/2018
2	Pathologic Processes 12/2016 - 12/2009
2	Macular Degeneration (Age-Related Maculopathy) 09/2010 - 12/2005
2	Hepatocellular Carcinoma (Hepatoma) 11/2007 - 04/2006
1	Colitis 01/2022
1	Carcinogenesis 01/2022
1	Erectile Dysfunction 01/2020
1	Ganglioneuroblastoma 09/2019
1	Ganglioneuroma 09/2019
1	Neuroblastoma 09/2019
1	Hemangioma (Angioma) 06/2018
1	Spontaneous Remission 06/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Retinal Diseases 12/2016

Drug/Important Bio-Agent (IBA)

16	pigment epithelium-derived factorIBA 01/2020 - 04/2002
13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 03/2002
8	Angiogenesis InhibitorsIBA 01/2020 - 03/2002
7	Proteins (Proteins, Gene)FDA Link 10/2019 - 04/2002
6	Retinaldehyde (Retinal)IBA 01/2017 - 04/2002
4	plasminogen kringle 5IBA 10/2017 - 03/2002
3	CateninsIBA 12/2021 - 05/2016
3	Nonesterified Fatty Acids (NEFA)IBA 10/2019 - 09/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 01/2012
3	Carrier Proteins (Binding Protein)IBA 05/2013 - 11/2007
3	AlkaliesIBA 05/2013 - 11/2005
3	Kallikreins (Kallikrein)IBA 05/2013 - 11/2007
2	Biological ProductsIBA 01/2022 - 12/2009
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 12/2014
2	Messenger RNA (mRNA)IBA 09/2019 - 01/2012
2	Therapeutic UsesIBA 06/2018 - 11/2005
2	EnzymesIBA 05/2018 - 07/2016
2	Recombinant ProteinsIBA 01/2018 - 06/2017
2	kallistatinIBA 01/2018 - 06/2017
2	Peptides (Polypeptides)IBA 12/2014 - 10/2010
2	Caspase 8 (Caspase-8)IBA 12/2014 - 07/2013
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Uncoupling Protein 1IBA 01/2021
1	MethyltransferasesIBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	oxidized low density lipoproteinIBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Propranolol (Inderal)FDA LinkGeneric 06/2018
1	LipidsIBA 05/2018
1	Vascular Endothelial Growth Factor CIBA 01/2018
1	Endoplasmic Reticulum Chaperone BiPIBA 10/2017
1	UbiquitinIBA 10/2017
1	VimentinIBA 01/2017
1	Cadherins (E-Cadherin)IBA 01/2017
1	nickel chlorideIBA 07/2016
1	Tumor Viral Antigens (Large T Antigen)IBA 07/2016
1	Histones (Histone)IBA 07/2016
1	NickelIBA 07/2016
1	Superoxide DismutaseIBA 05/2016
1	NestinIBA 03/2015
1	Death Domain ReceptorsIBA 12/2014
1	EpitopesIBA 12/2014
1	Fibronectins (Fibronectin)IBA 11/2014
1	Laminin ReceptorsIBA 11/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2014
1	AMP-Activated Protein KinasesIBA 01/2014
1	Adenosine Triphosphate (ATP)IBA 01/2014
1	AnthraquinonesIBA 01/2014
1	Oleic Acid (Oleate)IBA 01/2014
1	Lipase (Acid Lipase)FDA Link 09/2013
1	Triglycerides (Triacylglycerol)IBA 09/2013
1	Glycoproteins (Glycoprotein)IBA 09/2013
1	artemisinin (artemisinine)IBA 05/2013
1	ArtesunateIBA 05/2013
1	SerpinsIBA 05/2013

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2022 - 01/2014
3	Therapeutics 01/2020 - 09/2012
3	Intraperitoneal Injections 06/2010 - 11/2007